AORTIC aneurysm therapeutic targets have been identified through an integrated multi-omics investigation, with ADAMTS8 and IL6R emerging as promising candidates for future drug development.
The study combined genetic, transcriptomic and spatial analyses to investigate potential disease mechanisms, identify candidate therapeutic targets and explore tissue-specific factors associated with aortic aneurysm development.
Genetic Analysis Identifies Aortic Aneurysm Targets
Researchers conducted a two-sample Mendelian randomisation analysis involving 5,900 potentially druggable genes, using genetic variants associated with gene expression in blood and arterial tissues.
Findings were evaluated using protein quantitative trait locus analyses, summary-data-based Mendelian randomisation, heterogeneity testing and Bayesian co-localisation.
These complementary approaches identified ADAMTS8 and IL6R as candidate therapeutic targets for aortic aneurysm.
Phenome-wide analyses suggested that genetically predicted ADAMTS8 expression was associated with lower diastolic blood pressure but higher systolic blood pressure.
Meanwhile, genetically predicted IL6R expression was associated with reduced allergy risk.
The researchers also investigated whether cardiovascular and metabolic factors could help explain the association between IL6R and aortic aneurysm.
Mediation analyses suggested that coronary atherosclerosis accounted for approximately 10% of this association, while high-density lipoprotein accounted for 2.5%.
Drug Associations Offer Potential Treatment Directions
Exploratory gene–compound analysis identified four compounds associated with both ADAMTS8 and IL6R: cyclopenthiazide, primaquine, decitabine and progesterone.
These findings provided preliminary hypotheses for future therapeutic investigations rather than evidence of clinical effectiveness against aortic aneurysm.
Researchers also examined biological pathways and potential safety associations to provide additional context for the identified genetic targets.
However, the findings remain computational and require experimental confirmation before their therapeutic relevance can be established.
Spatial Analysis Reveals Tissue-Specific Genetic Signals
To investigate tissue-specific disease mechanisms, researchers integrated abdominal aortic aneurysm genetic data with spatial transcriptomic information from embryonic mouse tissues.
The analysis identified 10 nominally associated tissue regions, with the strongest signals involving the submandibular gland, lung, connective tissue and adipose tissue.
However, none of these associations remained statistically significant after correction for multiple testing.
Three genes, DLK1, COL3A1 and LGALS1, emerged as leading candidates from the spatial prioritisation analysis.
Single-cell RNA sequencing additionally identified 10 major cellular lineages within abdominal aortic aneurysm tissues.
IL6R expression was numerically higher in aneurysm tissues than in controls, although this difference was not statistically significant. ADAMTS8 expression remained relatively low across cellular populations.
Overall, the study highlighted ADAMTS8 and IL6R as potential aortic aneurysm therapeutic targets while identifying additional tissue-specific genetic signals.
Further experimental and clinical validation is needed to establish their biological relevance, safety implications and potential therapeutic applications.
Reference
Liu R. Integrated Spatial Transcriptomics and GWAS-Associated Analysis Reveal Risk Genes and Potential Therapeutic Targets for Aortic Aneurysm. Artery Res. 2026.